Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Sell Newport Corporation (NEWP)

Page 1 of 2

Is it smart to be bullish on Newport Corporation (NASDAQ:NEWP)?

At the moment, there are plenty of gauges investors can use to analyze stocks. A couple of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite investment managers can outpace the market by a very impressive margin (see just how much).

Just as crucial, optimistic insider trading sentiment is another way to analyze the marketplace. There are a variety of motivations for an executive to drop shares of his or her company, but only one, very simple reason why they would initiate a purchase. Several empirical studies have demonstrated the useful potential of this method if you understand where to look (learn more here).

Now that that’s out of the way, let’s analyze the latest info surrounding Newport Corporation (NASDAQ:NEWP).

What have hedge funds been doing with Newport Corporation (NASDAQ:NEWP)?

At the end of the second quarter, a total of 12 of the hedge funds we track were bullish in this stock, a change of -8% from the previous quarter. With hedge funds’ sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were upping their holdings meaningfully.

Newport Corporation (NASDAQ:NEWP)Out of the hedge funds we follow, Chuck Royce’s Royce & Associates had the largest position in Newport Corporation (NASDAQ:NEWP), worth close to $47.5 million, comprising 0.1% of its total 13F portfolio. Sitting at the No. 2 spot is Michael Kaufman of MAK Capital One, with a $8.4 million position; the fund has 2% of its 13F portfolio invested in the stock. Other peers that hold long positions include Joel Greenblatt’s Gotham Asset Management, Cliff Asness’s AQR Capital Management and Glenn Russell Dubin’s Highbridge Capital Management.

Because Newport Corporation (NASDAQ:NEWP) has experienced a fall in interest from the smart money’s best and brightest, we can see that there were a few fund managers who sold off their positions entirely heading into Q2. Interestingly, Thomas E. Claugus’s GMT Capital sold off the biggest stake of all the hedgies we key on, totaling an estimated $9.2 million in stock, and David Moradi of Anthion Management was right behind this move, as the fund said goodbye to about $1.6 million worth. These transactions are intriguing to say the least, as total hedge fund interest fell by 1 funds heading into Q2.

What have insiders been doing with Newport Corporation (NASDAQ:NEWP)?

Insider buying is best served when the company we’re looking at has seen transactions within the past half-year. Over the latest six-month time period, Newport Corporation (NASDAQ:NEWP) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Newport Corporation (NASDAQ:NEWP). These stocks are Edgen Group Inc (NYSE:EDG), Wesco Aircraft Holdings Inc (NYSE:WAIR), DXP Enterprises Inc (NASDAQ:DXPE), RTI International Metals, Inc. (NYSE:RTI), and Susser Petroleum Partners LP (NYSE:SUSP). This group of stocks are the members of the industrial equipment wholesale industry and their market caps are closest to NEWP’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!